Skip to main content

Table 1 Patient demographics

From: Functional alterations of myeloid cells during the course of Alzheimer’s disease

Diagnosis

CDR

Number

M,F

Age, yr. ± SD

Control

CDR 0

54

30, 24

69.81 ± 6.52

Prodromal AD

CDR0.5

44

21, 23

73.57 ± 6.57

Mild AD Dementia

CDR1

25

10, 15

74.48 ± 7.98

Moderate/Severe AD Dementia

CDR2/3

28

9, 19

71.29 ± 8.52